$AVTX 4 SEC Filings

Filed On	Filing
02 Oct 2026	Form 4: Philip Ron M, Director Granted 1,109 Stock Option (Right to Buy) ($13.6K)
02 Oct 2026	Form 4: Jain Rita, Director Granted 1,322 Stock Option (Right to Buy) ($16.2K)
02 Oct 2026	Form 4: Lind Kevin Robert, Director Granted 1,352 Stock Option (Right to Buy) ($16.6K)
18 Sep 2026	Form 4: Sullivan Christopher Ryan, Chief Financial Officer Received 12,394 shares by exercise or conversion ($122K) · Sold 12,394 shares ($202K)
11 Sep 2026	Form 4: Sullivan Christopher Ryan, Chief Financial Officer Received 10,185 shares by exercise or conversion ($81.9K) · Sold 10,185 shares ($179K)
01 Sep 2026	Form 4: Doyle Mittie, Chief Medical Officer Received 679 shares by exercise or conversion ($5.46K) · Sold 679 shares ($13.6K)
19 Aug 2026	Form 4: Sullivan Christopher Ryan, Chief Financial Officer Received 40,821 shares by exercise or conversion ($403K) · Sold 41,694 shares ($828K) · Received 31,031 shares by exercise or conversion ($307K) · 1 more
19 Aug 2026	Form 4: Doyle Mittie, Chief Medical Officer Received 1,000 shares by exercise or conversion ($12.7K) · Sold 1,000 shares ($20K)
12 Aug 2026	Form 4: Riley Jennifer, Chief Strategy Officer Sold 2,655 shares ($52K)
12 Aug 2026	Form 4: Doyle Mittie, Chief Medical Officer Received 679 shares by exercise or conversion ($5.46K) · Sold 679 shares ($13.6K)
29 Jul 2026	Form 4: Doyle Mittie, Chief Medical Officer Received 1,000 shares by exercise or conversion ($12.7K) · Sold 1,000 shares ($20K)
02 Jul 2026	Form 4: Philip Ron M, Director Granted 69 Stock Option (Right to Buy) ($1.04K)
02 Jul 2026	Form 4: Doyle Mittie, Chief Medical Officer Received 4,654 shares by exercise or conversion ($50.7K) · Sold 4,654 shares ($93.1K)
02 Jul 2026	Form 4: Lind Kevin Robert, Director Granted 1,105 Stock Option (Right to Buy) ($16.6K)
02 Jul 2026	Form 4: Jain Rita, Director Granted 1,080 Stock Option (Right to Buy) ($16.2K)
25 Jun 2026	Form 4: Doyle Mittie, Chief Medical Officer Received 1,450 shares by exercise or conversion ($11.7K) · Sold 1,450 shares ($26.1K)
25 Jun 2026	Form 4: Philip Ron M, Director Granted 40,200 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Riley Jennifer, Chief Strategy Officer Gave up 588 shares to cover exercise price or tax ($7.7K)
12 Jun 2026	Form 4: Varki Paul, Chief Legal Officer Gave up 1,081 shares to cover exercise price or tax ($14.2K)
12 Jun 2026	Form 4: Sullivan Christopher Ryan, Chief Financial Officer Gave up 138 shares to cover exercise price or tax ($1.81K)

Comments